Listed by the USPTO as KRETZER, KYLE W.
Tech Center 3700 • Art Units: 3774 3791 3796
This examiner grants 65% of resolved cases
KRETZER, KYLE W. works in Tech Center 3700 and Art Unit 3774. The record covers 187 resolved cases, with an allowance rate of 64.7% and a median of 1281 days to allowance. The interview lift is 40.6%, indicating a favorable association between interviews and allowance outcomes.
The leading companies are The Regents of the University of California, Abbott Laboratories, and Roche Diabetes Care Inc. The listed firms are DINSMORE & SHOHL LLP, ARENTFOX SCHIFF LLP - New York, and Bookoff McAndrews, PLLC. These participants provide a useful starting point for reviewing related prosecution histories.
The case volume supports using the interview measure as a meaningful planning signal. Counsel may benefit from a structured interview strategy, while still tailoring amendments and arguments to the application record.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18810419 | CONTROLLING PATIENT MONITORING DEVICES | Non-Final OA | Cilag GmbH International |
| 18729383 | A Machine Learning Pipeline for Highly-Sensitive Assessment of Rotator Cuff Function | Final Rejection | The Regents of the University of California |
| 19080266 | Computing Device Having Miniaturized Impedance Plethysmography Sensor for Measuring Blood Flow | Non-Final OA | Google LLC |
| 18830480 | DEVICES AND METHODS FOR THE MITIGATION OF NON-ANALYTE SIGNAL PERTURBATIONS INCIDENT UPON ANALYTE-SELECTIVE SENSOR | Non-Final OA | Biolinq Incorporated |
| 17628598 | DETECTING APPARATUS AND DETECTING METHOD | Final Rejection | MAXELL, LTD. |
| 18289608 | BIOLOGICAL INFORMATION ACQUISITION DEVICE, BIOLOGICAL INFORMATION ACQUISITION METHOD, AND RECORDING MEDIUM | Final Rejection | NEC Corporation |
| 19055255 | HOME-BASED LABOR ONSET DETECTION SYSTEM AND METHOD | Non-Final OA | GE Precision Healthcare LLC |
| 19018361 | SYSTEM, APPARATUS, AND METHOD FOR EVALUATING VASCULAR ENDOTHELIAL FUNCTION | Non-Final OA | Murata Manufacturing Co., Ltd. |
| 19074133 | TRANSCUTANEOUS SENSOR WITH DUAL ELECTRODES AND METHODS OF DETECTING AND COMPENSATING FOR WITHDRAWAL OF A TRANSCUTANEOUS SENSOR FROM A PATIENT | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 18705641 | SYSTEMS, DEVICES, AND METHODS FOR ANALYTE MONITORING | Final Rejection | ABBOTT DIABETES CARE INC. |
| 18147755 | SYSTEMS AND METHODS FOR ANALYTE MONITORING | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 17008101 | ADJUSTING SETTINGS TO DIFFERENT DEGREES OF AGGRESSIVENESS IN AN AUTOMATED INSULIN DELIVERY SYSTEM BASED ON QUALITY OF BLOOD GLUCOSE LEVEL CONTROL BY A USER | Final Rejection | Insulet Corporation |
| 18315858 | METHOD FOR PRODUCING AN ANALYTE SENSOR, AN ANALYTE SENSOR, AND A USE THEREOF | Non-Final OA | Roche Diabetes Care, Inc. |
| 18307071 | ANALYTE SENSOR SYSTEM AND A METHOD FOR ITS PRODUCING | Final Rejection | Roche Diabetes Care, Inc. |
| 18535086 | GUIDE WIRE | Non-Final OA | ASAHI INTECC CO., LTD. |
| 18636187 | OMNIPHOBIC PAPER BASED SMART BANDAGE DEVICES | Non-Final OA | Purdue Research Foundation |
| 18856968 | Systems, methods and devices for assessing hearing | Non-Final OA | THE BIONICS INSTITUTE OF AUSTRALIA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy64.7% of resolved applications examined by Kyle W. Kretzer were allowed (187 resolved cases), compared with 61.7% across Art Unit 3774 over the last five years.
This examiner's interview lift is +40.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Kyle W. Kretzer took 1,281 days on average from filing to allowance.
Kyle W. Kretzer examines applications in Art Unit 3774 in Tech Center 3700 (Medical Devices & Mechanical Engineering).